Replies to post #2043 on Biotech Values

[DewDiligence]

Re: GNTA:

>> Did you look at the p values? I believe that they were around .18!!! <<

The high p-value was discussed on GNTA’s prior CC, and GNTA’s assertion was that the results would look vastly better when patients were followed a little longer. This is the claim the FDA may find wanting.